Undertreatment of hypertension in a population-based study in The Netherlands

Journal of Hypertension

Volumn 16, Issue 9, 1998, Pages 1371-1378

  Klungel, Olaf H ^a   De Boer, Anthonius ^a   Paes, Arsenio H P ^a   Seidell, Jacob C ^b   Nagelkerke, Nico J D ^b   Bakker, Albert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Hypertension; Risk factors; Undertreatment; Within person variability

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0031679240     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816090-00018     Document Type: Article

References (67)

1. The Principal Investigators of the MONICA Project. WHO MONICA Project: geographic variation in mortality from cardiovascular diseases-baseline data on selected population characteristics and cardiovascular mortality. World Health Stat Q 1987; 40:171-184.
2. Uemura K, Pisa Z. Recent trends in cardiovascular disease mortality in 27 industrialized countries. World Health Stat Q 1985; 38:142-162.
3. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
4. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994; 50:272-298.
5. Du X, Cruickshank K, McNamee R, Saraee M, Sourbutts J, Summers A, et al. Case-control study of stroke and the quality of hypertension control in north west England. BMJ 1997; 314:272-276.
6. The WHO MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. World Health Stat Q 1988; 41:115-139.
7. Smith WCS, Lee AJ, Crombie IK, Tunstall-Pedoe H. Control of blood pressure in Scotland: the rule of halves. BMJ 1990; 300:981-983.
8. Stamler J, Stamler R, Riedlinger WF, Algera G, Roberts RH. Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) Program, 1973 through 1975. JAMA 1976; 235:2299-2306.
9. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
10. Wagner EH, James SA, Beresford SAA, Strogatz DS, Grimson RC, Kleinbaum DG, et al. The Edgecombe County high blood pressure control program: I. Correlates of uncontrolled hypertension at baseline. Am J Public Health 1984; 74:237-242.
11. Entwisle G, Scott JC, Apostolides AY, Southard J, Su S, Brandon B, et al. A survey of blood pressure in the state of Maryland. Prev Med 1983; 12:695-708.
12. Folmson AR, Luepker RV, Gillum RF, Jacobs DR, Prineas RJ, Taylor HL, et al. Improvement in hypertension detection and control from 1973-1974 to 1980-1981. The Minnesota Heart Survey experience. JAMA 1983; 250:916-921.
13. Huhtasaari F, Asplund K, Wester PO. Cardiovascular risk factors in the Northern Sweden MONICA study. Acta Med Scand 1988; 224:99-108.
14. Tuomilehto J, Nissinen A, Wolf E, Geboers J, Piha T, Puska P. Effectiveness of treatment with antihypertensive drugs and trends in mortality from stroke in the community. BMJ 1985; 291:857-861.
15. Salomaa V, Tuomilehto J, Kartovaara L, Marti B, Nissinen A, Korhonen HJ, et al. Trends in cardiovascular risk factors in treated and untreated hypertensive and normotensive Finnish subjects, 1982-1987. Rev Epidemiol Sante Publ 1990; 38:493-500.
16. Hense HW, Stieber J, Filipiak B, Keil U. Five-year changes in population blood pressure and hypertension prevalence: results from the MONICA Augsburg Surveys 1984/85 and 1989/90. Ann Epidemiol 1993; 3:410-416.
17. Keil U, Remmers A, Chambless L, Hense HW, Stieber J, Lauck A. Epidemiologie des bluthochdruckes. Häufigkeit, Verteilung, bekanntheits-und behandlungsgrad der hypertonie in de hansestadt Lübeck. Ergebnisse der Lübecker blutdruckstudie und vergleich mit daten def Münchener blutdruckstudie [in German]. Münch Med Wochenschr 1986; 128:424-429.
18. Shelley E, Daly L, Collins C, Christie M, Conroy R, Gibney M, et al. Cardiovascular risk factor changes in the Kilkenny Health Project. Eur Heart J 1995; 16:752-760.
19. Jackson RT, Beaglehole R, Stewart AW. Blood pressure levels and treatment of hypertension in Auckland, 1982. NZ Med J 1983; 96:751-754.
20. Jackson R, Beaglehole R, Yee RL, Small C, Scragg R. Trends in cardiovascular risk factors in Auckland, 1982 to 1987. NZ Med J 1990; 103:363-365.
21. Plans P, Pardell H, Salleras LI. Epidemiology of cardiovascular disease risk factors in Catalonia (Spain). Eur J Epidemiol 1993; 9:381-389.
22. Verschuren WMM, Leer van EM, Blokstra A, Seidell JC, Smit HA, Bueno de Mesquita HB, et al. Cardiovascular disease risk factors in The Netherlands. Neth J Cardiol 1993; 4:205-210.
23. Sempos CT, Looker AC, Johnson CL, Woteki CE. The importance of within-person variability in estimating prevalence. In: Willett WC (editor). Nutritional epidemiology. Oxford: Oxford University Press; 1990. pp. 99-109.
24. Strachan D, Rose G. Strategies of prevention revisited: effects of imprecise measurement of risk factors on the evaluation of 'high-risk' and 'population-based' approaches to prevention of cardiovascular disease. J Clin Epidemiol 1991; 40:1187-1196.
25. Birkett NJ. The effect of alternative criteria for hypertension on estimates of prevalence and control. J Hypertens 1997; 15:237-244.
26. Armitage P, Fox W, Rose GA, Tinker CM. The variability of measurements of casual blood pressure. II. Survey experience. Clin Sci 1966; 30:337-344.
27. Core Services Committee. Guidelines for the management of mildly raised blood pressure in New Zealand. Wellington: Ministry of Health; 1995.
28. Sever P, Beavers G, Bulpitt C, Lever A, Ramsey L, Reid J, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993; 306:983-987.
29. NHG. Standaard hypertensie [in Dutch]. Huisarts Wetenschap 1997, 40:598-617.
30. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Washington, DC: NIH Publication no. 98-4080, 1997.
31. Zanchetti A, Chalmers JP, Arakawa K, Gyarfas I, Hamet P, Hansson L, et al. The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press 1993; 2:86-100.
32. Kraus JF, Borhani NO, Franti CE. Socioeconomic status, ethnicity, and risk factors of coronary heart disease. Am J Epidemiol 1980; 111:407-414.
33. Jacobsen BK, Thelle DS. Risk factors for coronary heart disease and level of education: the Tromso Heart Study. Am J Epidemiol 1988; 127:923-932.
34. Duijkers TJ, Kromhout D, Spruit IP, Doornbos G. Intermediating risk factors in the relation between socioeconomic status and 25-year mortality (the Zutphen Study). Int J Epidemiol 1989; 18:658-662.
35. Shepard DS. Reliability of blood pressure measurements: implications for designing and evaluating programs to control hypertension. J Chronic Dis 1981; 34:191-209.
36. Rosner B, Polk BF. The implications of blood pressure variability for clinical and screening purposes. J Chronic Dis 1979; 32:451-461.
37. Miettinen OS. Estimation of relative risk from individually matched series. Biometrics 1970; 26:75-86.
38. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988; 259:225-228.
39. Byrd LH, Gutkin M, Spizner R, Novembre C, Krieger J. White-coat effect tends to endure over time [abstract]. Am J Hypertens 1988; 1 (suppl I):80.
40. Krakoff LR, Eison H, Phillips RH, Leiman SH, Levy S. Effect of ambulatory pressure monitoring on the diagnosis and cost of treatment for mild hypertension. Am Heart J 1988; 116:1152-1154.
41. Lerman CE, Brody DS, Hui T, Lazaro C, Smith DG, Blum MJ. The white coat hypertension response: prevalence and predictors. J Gen Intern Med 1989; 4:225-231.
42. Glen SK, Elliott HL, Curzio JL, Lees KR, Reid JL. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet 1996; 348:654-657.
43. O'Brien E, Mee F, Atkins N, O'Malley K. Inaccuracy of the Hawksley random zero sphygmomanometer. Lancet 1990; 336:1465-1468.
44. McGurk C, Nugent A, McAuley D, Silke B. Sources of inaccuracy in the use of the Hawksley random zero sphygmomanometer. J Hypertens 1997; 15:1379-1384.
45. Mackie A, Whincup P, McKinnon M. Does the Hawksley random zero sphygmomanometer underestimate blood pressure and by how much? J Hum Hypertens 1995; 9:337-343.
46. Brown WCB, Kennedy S, Inglis GC, Murray LS, Lever AF. Mechanisms by which the Hawksley random zero sphygmomanometer underestimates blood pressure and produces a non-random distribution of RZ values. J Hum Hypertens 1997; 11:75-93.
47. Kronmal RA, Rutan GH, Manolio TA, Borhani NO. Properties of the random zero sphygmomanometer. Hypertension 1993; 21:632-637.
48. Birkett NJ. Potential problems with the random-zero sphygmomanometer. Hypertension 1994; 23:254-257.
49. Rose GA, Holland WW, Crowley EA. A sphygmomanometer for epidemiologists. Lancet 1964; i:296-300.
50. Alderman MH, Budner N, Cohen H, Lamport B, Ooi WL. Prevalence of drug resistant hypertension. Hypertension 1988; 11 (suppl II):II71-II75.
51. Peterson GM, McLean S. Determinants of patient compliance and clinical response in general practice treatment of hypertension. Med J Aust 1982; 2:230-233.
52. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health 1994; 84:1768-1774.
53. Haynes RB, Gibson ES, Hackett BC, Sackett DL, Taylor DW, Roberts RS, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet 1976; i:1265-1268.
54. Morisky DE, DeMuth NM, Field-Fass M, Green LW, Levine DM. Evaluation of family health education to build social support for long-term control of high blood pressure. Health Educ Q 1985; 12:35-50.
55. Eisen SE, Woodward RS, Miller D, Spitznagel E, Windham CA. The effect of medication compliance on the control of hypertension. J Gen Intern Med 1987; 2:298-305.
56. Wilber JA, Barrow JG. Hypertension: a community problem. Am J Med 1972, 52:653-663.
57. Gifford RW, Cooper ES, Hill M, Kaplan NM, Moser M. McFate Smith W, et al. Hypertension Study Group, inter-society commission for heart disease resources: guidelines for detection, diagnosis and management of hypertensive populations. Circulation 1981; 64:1079A-1089A.
58. Marcus AC, Siegel JM. Gender differences in the use of the physician services. J Health Soc Behav 1982; 23:186-197.
59. Nathanson CA. Illness and the feminine role: a theoretical review. Soc Sci Med 1975; 9:57-62.
60. Nathanson CA. Sex, illness, and medical care: a review of data, theory, and method. Soc Sci Med 1977; 11:13-25.
61. Nathanson CA. Sex roles as variables in the interpretation of morbidity data: a methodological critique. Int J Epidemiol 1978; 7:253-262.
62. Waldron I. Sex differences in illness incidence, prognosis and mortality: issues and evidence. Soc Sci Med 1983; 17:1107-1123.
63. Verbrugge LM. Sex differentials in health. Pub Health Rep 1982; 5:417-437.
64. McClellan WM, Hall D, Brogan D, Miles C, Wilber JA. Continuity of care in hypertension: an important correlate of blood pressure control among aware hypertensives. Arch Intern Med 1988; 148:525-528.
65. Degoulet P, Menard J, Vu HA, Golmard JL, Devries C, Chatellier G, et al. Factors predictive of attendance at clinic and blood pressure control in hypertensive patients. BMJ 1983, 287:88-93.
66. Ballard DJ, Strogatz DS, Wagner EH, Siscovick DS, James SA, Kleinbaum DG, et al. Hypertension control in a rural southern community: medical care process and dropping out. Am J Prev Med 1988; 4:133-139.
67. Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G, for the Canadian Heart Health Surveys Research Group. Prevalence, control and awareness of high blood pressure among Canadian adults. Can Med Assoc J 1992; 146:1997-2005.